XBIOTECH
XBiotech is a biopharmaceutical company developing first-in-class antibody therapies. The Company’s lead product candidate inhibits chronic (sterile) inflammation – a condition involved in the progression of many serious and common diseases. The Company has several groundbreaking clinical trial programs in different areas of medicine including dermatology, oncology, diabetes, cachexia and cardiovascular disease.
XBIOTECH
Industry:
Biotechnology Health Care Medical
Founded:
2005-01-01
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.xbiotech.com
Total Employee:
51+
Status:
Active
Contact:
512-386-2900
Technology used in webpage:
SPF SSL By Default LetsEncrypt Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail IPv6 Google Maps ReCAPTCHA
Similar Organizations
AtheroGenics
AtheroGenics is a pharmaceutical company developing Antioxidants.
Braasch Biotech LLC
Braasch Biotech LLC is a biopharmaceutical company working exclusively with therapeutic vaccines.
ImmunoGenes
ImmunoGenes is a biopharmaceutical company developing a platform which improves the immune system's response.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
POINT Biomedical
Point Biomedical is a pharmaceutical company developing technologies for imaging and drug deliveries.
Quorum Innovations
Quorum Innovations is a biopharmaceutical company that focuses on developing human microbiome therapeutics.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.xbiotech.com Semrush global rank: 4.11 M Semrush visits lastest month: 2.94 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "XBiotech"
XBiotech - Wikipedia
XBiotech was founded in 2005 in Vancouver, Canada by John Simard. The company moved its headquarters to Austin, Texas in 2008. In September 2016, XBiotech was listed on Nasdaq, raising $70.9 million through its initial public offering (IPO). The company allocated about $42 million of the proceeds to complete later-stage trials for one of its key cancer drugs and to construct a new manufacturing and research facility …See details»
XBiotech - Crunchbase Company Profile & Funding
XBiotech is a biopharmaceutical company developing antibody therapies. XBiotech may be growing as it is reported that the company is doubling down on its campus, which indicates an …See details»
About XBiotech — XBiotech
XBiotech has a fully integrated research and manufacturing center and a separate infectious disease research laboratory at its campus headquarters in Austin, Texas.See details»
Investor Overview - XBiotech
Nov 22, 2024 5217 Winnebago Ln. Austin, TX 78744 CALL: (512) 386- 2900 FAX: (512) 386-5505. [email protected]See details»
XBiotech Company Profile 2024: Stock Performance & Earnings
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for …See details»
XBiotech Inc - Company Profile and News - Bloomberg Markets
XBiotech Inc. is a clinical-stage biopharmaceutical company. The Company discovers and develops monoclonal antibodies for treating a variety of diseases, such as cancer, vascular …See details»
XBiotech - Products, Competitors, Financials, Employees, …
XBiotech is building on a foundation of remarkable new therapies, innovative approaches to commercialization and a commitment to realizing treatments for unmet medical needs worldwide.See details»
XBiotech - Funding, Financials, Valuation & Investors - Crunchbase
Apr 14, 2015 XBiotech is a biopharmaceutical company developing antibody therapies. Unlock even more features with Crunchbase ProSee details»
Financial Information - XBiotech
5217 Winnebago Ln. Austin, TX 78744 CALL: (512) 386- 2900 FAX: (512) 386-5505. [email protected]See details»
XBiotech - Contacts, Employees, Board Members, Advisors & Alumni
XBiotech is a biopharmaceutical company developing antibody therapies.See details»
XBiotech Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 XBiotech is a biosciences company dedicated to the discovery, development, and commercialization of therapeutic antibodies based on its True Human technology. Its …See details»
Xbiotech Inc (XBIT-Q) Stock Price and News - The Globe and Mail
Real-time Price Updates for Xbiotech Inc (XBIT-Q), along with buy or sell indicators, analysis, charts, historical performance, news and moreSee details»
XBiotech
Aug 21, 2023 XBiotech has a fully integrated research and manufacturing center and a separate infectious disease research laboratory at its campus headquarters in Austin, Texas.See details»
French National Cancer Institute and XBiotech Join forces to …
May 3, 2021 XBiotech is a fully integrated global biosciences company dedicated to pioneering the discovery, development and commercialization of therapeutic antibodies based on its True …See details»
XBiotech USA - Overview, News & Similar companies - ZoomInfo
Who is XBiotech USA. XBiotech is a fully integrated global biosciences company dedicated to pioneering the discovery, development and commercialization of therapeutic a ntibodies based …See details»
XBiotech, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
XBiotech is pioneering the discovery and development of targeted antibodies based on its True Human™ technology. The company’s mission is to rethink the way antibody medicines are …See details»
John Simard | Board Member - XBiotech
5217 Winnebago Ln. Austin, TX 78744 CALL: (512) 386- 2900 FAX: (512) 386-5505. [email protected]See details»
XBiotech Identifies “Super Bloods” for the Development of a True …
May 1, 2020 XBiotech is a fully integrated, global biopharmaceutical company dedicated to pioneering the discovery, development and commercialization of therapeutic antibodies.See details»
XBiotech Announces Collaboration with US Oncology Research in …
Sep 18, 2013 XBiotech plans to have 100 sites in the United States, with results intended to provide the basis for marketing approval. John Simard, CEO of XBiotech, commented "US …See details»